Merck Invests € 270 Million in a New Research Center and Vocational & Advanced Training
Merck KGaA
Merck KGaA
“Darmstadt is our site of the future. With these investments, we are underscoring the strategic importance of the site and our focus on sustainability and innovative ways of working,” said Kai Beckmann, CEO Electronics and Member of the Executive Board of Merck with responsibility for the Darmstadt site. “In addition, we will create an optimum working environment for many of our researchers as well as for our Vocational & Advanced Training unit.”
Innovative ways of working combined with science and sustainability
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies. This € 200 million investment will give rise to an integrated, flexible-use laboratory building covering more than 30,000 m², that includes a café, a lecture hall, in vitro laboratories including a cell bank, as well as a modern and flexible knowledge environment.
The new Learning Center will enable Merck to house training facilities for all vocational training occupations in one spacious building. Seven floors with a surface area of more than 14,000 m2 will offer space for laboratories, seminar rooms and workshops, among other things. The building will create sufficient room and an attractive environment for 50 employees from the Vocational Training department in order to prepare the company’s 600 apprentices for the workforce and their assignments within the company. Moreover, the Learning Center will be an important location for advanced training at Merck. The company is thus investing further to qualify its employees for the changing world of work. The building, which involves an investment of € 70 million, is expected to be ready for occupancy in 2024.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.